Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18507653 | 0.79 | CA1 (0.34) | — | |
| SCHEMBL18590363 | 0.78 | CPA1 (0.32) | — | |
| SCHEMBL17484747 | 0.75 | ALDH1A1 (0.32) | — | |
| SCHEMBL21626535 | 0.75 | POLB (0.41) | CYP2C19 | |
| SCHEMBL18507665 | 0.72 | ALDH1A1 (0.34) | — | |
| SCHEMBL11230782 | 0.67 | GAA (0.36) | — | |
| SCHEMBL9659709 | 0.67 | CYP2C19 (0.56) | CYP2C19CA2 | |
| SCHEMBL36990 | 0.65 | CYP2C19 (0.59) | CYP2C19CA2 | |
| Cyclohexane SCHEMBL10719730 | 0.63 | CYP2C19 (0.52) | CYP2C19CA2 | |
| SCHEMBL11370895 | 0.63 | CPA1 (0.43) | CYP2C19CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170066716-A1 | ENERGETIC N-SUBSTITUTED 3, 3-DINITROAZETIDINE PLASTICIZER AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-03-09 | — | — | US | disclosed |
| US-9573894-B1 | Energetic N-substituted 3, 3-dinitroazetidine plasticizer and preparation method thereof | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-02-21 | — | — | US | disclosed |
| US-9573894-B1 | Energetic N-substituted 3, 3-dinitroazetidine plasticizer and preparation method thereof | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-02-21 | — | — | US | disclosed |
| US-9573894-B1 | Energetic N-substituted 3, 3-dinitroazetidine plasticizer and preparation method thereof | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170066716-A1 | ENERGETIC N-SUBSTITUTED 3, 3-DINITROAZETIDINE PLASTICIZER AND PREPARATION METHOD THEREOF | NFE2L2, NQO1, NBAS | CYP2C19 32/4885CA2 3026/4885NLRP3 4559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.